Back
Speaker illustration

Mr Daniel Filipe Inacio Cazeiro

Hospital Santa Maria, Lisbon (Portugal)

Presentations Articles

SGLT2i on transthyretin amyloid cardiomyopathy - a new drug for an under-recognized cardiomyopathy

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy 5

Access
Like
Thumbnail

Residual pulmonary hypertension after PEA - an ill-defined problem

Event: Heart Failure 2024

Topic: Pulmonary Hypertension

Session: Myocardial disease - clinical 2

Access
Like
Thumbnail

Echocardiographic estimation of right atrial pressure in pulmonary hypertension: a reliable tool?

Event: Heart Failure 2024

Topic: Pulmonary Hypertension

Session: Myocardial disease - clinical 2

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources